CureVac sues BioNTech over mRNA technology

07-07-2022

CureVac sues BioNTech over mRNA technology

rafapress / Shutterstock.com

Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid (mRNA) technology.


CureVac, BioNTech, patent infringement, COVID-19, mRNA, vaccines, vaccination, messenger ribonucleic acid, Comirnaty

LSIPR